Abstract:Supported by the experience and data from the Southlake in Canada and other centers, this paper compares the outcomes for ventricular tachycardia ablation between the patients with ischemic cardiomyopathy(ICM) and nonischemic cardiomyopathy(NICM). It implies that the outcomes are better for substratebased ablation in ICM patients compared with the outcomes in NICM patients. However, it is challenging to identify NICM substrates. Longterm outcomes for VT ablation remain worse in NICM patients than those in ICM patients. But if the reduction of VT burden is regarded as a main target rather than complete cure, the outcomes are still acceptable.
Atul Verma. 缺血性和非缺血性心肌病患者室速基质消融疗效比较[J]. 实用心电学杂志, 2017, 26(4): 247-255.
Atul Verma. Comparison of substrate and outcomes for ventricular tachycardia ablation between the patients with ischemic and nonischemic cardiomyopathy. JOURNAL OF PRACTICAL ELECTROCARDIOLOGY, 2017, 26(4): 247-255.